Milestone Pharmaceuticals to Present Clinical Data on Etripamil at the American College of Cardiology
Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present ...
Spring allergy season is around the corner. Here's what you can do to deal with congestion.
The start of spring kicks off a nasal nuisance for many people, but one drug meant to clear congestion has struggled to do ...
Business Insider10d
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update
FDA PDUFA review goal date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia (PSVT) Assuming FDA approval, proposed launch in PSVT targeted for ...
Healio18d
FDA approves epinephrine nasal spray for children aged as young as 4 years
Payment options are available based on insurance coverage. The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 ...
pulmonologyadvisor24d
FDA Drug Approval Decisions Expected in March 2025
Efficacy was established in multiple clinical trials including the phase 3 NODE-301 trial (ClinicalTrials.gov Identifier: NCT03464019), which evaluated the efficacy and safety of self-administered ...
USA Today25d
Nasal wash recalled nationwide over bacteria risk: What to know
A nasal cleansing wash sold nationwide is being recalled because the product may be contaminated with bacteria, according to a notice posted this week by the U.S. Food and Drug Administration.
Local 12 WKRC Cincinnati25d
Nasal spray recalled for 'potentially life-threatening' bacterial contamination
CINCINNATI (WKRC) - The Food and Drug Administration issued a recall for certain nasal spray that tested positive for a bacterial contaminate that could lead to "potentially life-threatening ...
Yahoo Finance27d
Milestone Pharmaceuticals Inc. (MIST)
Investors planning to attend the in-person event are required to register in advance. - PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular Tachycardia ...
Medical Xpress27d
1 in 10 older South Asian immigrants in Canada have hypothyroidism
Get Instant Summarized Text (Gist) Approximately 10% of South Asian immigrants aged 45 and older in Canada have hypothyroidism, with a 77% higher likelihood compared to Canadian-born individuals ...